undamentalytics Newsletter
Sign in

Evolent Health, Inc. cash flow statement

In fiscal 2025, Evolent Health, Inc.'s operations generated $38.8m of cash; it spent $0 on capital projects, leaving free cash flow of $38.8m. It returned $40.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−36−28−21−43−1639−12143193954
Depreciation and amortisation17324561616067123118116112
Stock-based pay1920181615173441404043
Capital spending162840360000000
Free cash flow−51−56−60−78−1639−12143193954
Free cash flow after stock pay−70−76−78−94−3122−46102−21−111
Share buybacks———————0040—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: EVH vs RDNTEVH vs PRVAEVH vs HIMS

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Evolent Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Evolent Health, Inc.